•  
  •  
 

Document Type

systematic-review

Abstract

Background: Existing palatal tissue is used in traditional cleft palate repair techniques to achieve closure. Insufficient palate length, improper positioning of the velar musculature, and scarring and development limitation are possible outcomes of these surgeries. buccinator myomucosal flap provide extra tissue and limits these drawbacks. Objective: to clarify the indication, limitation, draw backs of clinical application of buccinator myomucosal flap in primary repair of cleft palate with systematic review in English written papers since 2016. Patients and Methods: Systematic review was accomplished utilising the PRISMA statement, or preferred reporting items for systemic review and meta-analysis. The study obtained information about articles that were published between 2010 and 2022. The analysis covered all published publications examining the role of the buccinators myomucosal flap in the primary repair of cleft palate. Results. The included number of patients in this review study was 540 cases. the average defect reported in all studies was 1.25 cm and the main age was 12,5 months, the palatal lengthening outcome after myomucosal flap increased by 8.4 mm in average. the incidence of fistula reduced from 6.5 %to 5%. 90% of the cases with normal speech .and only 6.6% of the patients needed secondary speech surgery. Conclusion: Regarding speech result, VPI, and fistula occurrence, primary palate repair with the buccal myomucosal flap has been a successful procedure. It permits nasal layer lengthening, excellent levator muscle sling restoration and retro placement, tension-free palate closure, and the lack of raw areas that could hinder facial growth. Further comparative studies with other techniques with large sample size and long follow up may be beneficial to find out the best procedure in terms of outcome and complication.

Keywords

Buccinator; myomucosal flap; primary repair; cleft palate; Systematic review

Subject Area

Plastic surgery

Share

COinS